Target coverage of daily cone-beam computed tomography in breath-hold image-guided radiotherapy for gastric lymphoma

OBJECTIVESWe evaluated retrospectively the daily target coverage using cone-beam computed tomography (CBCT) in breath-hold image-guided radiotherapy (BH-IGRT) for gastric lymphoma. METHODSBH-IGRT was performed using a prescribed dose of 30.6 Gy in 17 fractions for the whole stomach. We assessed the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BJR open 2021-01, Vol.3 (1), p.20200062-20200062
Hauptverfasser: Takahashi, Shigeo, Nishide, Takamasa, Tsuzuki, Masato, Katayama, Hiroki, Anada, Masahide, Kinoshita, Toshifumi, Kozai, Shohei, Shibata, Toru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OBJECTIVESWe evaluated retrospectively the daily target coverage using cone-beam computed tomography (CBCT) in breath-hold image-guided radiotherapy (BH-IGRT) for gastric lymphoma. METHODSBH-IGRT was performed using a prescribed dose of 30.6 Gy in 17 fractions for the whole stomach. We assessed the target coverage of the whole stomach on daily CBCT images [daily clinical target volume (CTV)], which was delineated individually by two observers. We evaluated V95% (percentage of volume receiving ≥95% of the prescribed dose) of daily CTV. RESULTSIn total, 102 fractions from 6 patients were assessed. The mean V95% of daily CTV was 97.2%, which was over 95%. In two of six patients, the V95% of daily CTV was over 95% for either observer in all fractions. One patient had significant interobserver variation (p = 0.013). In 95 fractions (93%), the V95% of daily CTV was over 95% for either observer. CONCLUSIONDaily target coverage for CTV in BH-IGRT for gastric lymphoma seems to be favorable, even when using CBCT. ADVANCES IN KNOWLEDGEA previous study ascertained good daily target coverage in BH-IGRT for gastric lymphoma using in-room CT. Even when using CBCT in our study, daily target coverage for CTV in BH-IGRT for gastric lymphoma seems to be favorable.
ISSN:2513-9878
2513-9878
DOI:10.1259/bjro.20200062